Uncategorized
Pfizer Shares Gain Amid Reports of Deal with the US Government
Pfizer stock climbed over 3% on news of an impending drug-pricing deal with the Trump administration.
Total Stories
19
News
Pfizer
Section
Pfizer
Market Analysis
Santa Claus Rally: 3 Discounted Stocks Heading into 2026
Pfizer’s comeback, Newmont’s resilience, and Utz’s growth positioning make them compelling candidates for year-end gains.
Market Analysis
MTSR Shares Jump After Pfizer Merger Agreement
Metsera stock skyrocketed 62% as Pfizer struck a $4.9 billion acquisition agreement focused on obesity therapies.
Best Stocks
3 Value Stocks Worth Buying in Current Market Conditions
Big Pharma, Big Tech and REIT is on the value menu. Discount opportunities at this level are rare.
Market Analysis
Pfizer Targets Up to $64B Revenue in 2025 Amid Strategic Cost Savings
Pfizer projects 2025 revenues between $61 billion and $64 billion, with a focus on cost savings and strategic initiatives to drive growth.
Market Analysis
Starboard Value Reportedly Acquires $1B Stake in Pfizer as Stock Lags S&P 500 by 46%
Activist investor Starboard Value has reportedly taken a $1 billion stake in pharmaceutical giant Pfizer.
Best Stocks
Top 3 Discounted Value Stocks Worth Buying Now
These stocks have a large cushion while retaining intrinsic value.
Market Analysis
The Weight Loss Market Can Surge to $400 B by 2032, and these Stocks Will Rule it
Despite Novo Nordisk's momentum, Eli Lilly seems a better long-term bet. Pfizer could surprise everyone from an undervalued position.
Market Analysis
Wall Street Weighs in as Pfizer Targets $100 Billion Weight Loss Market
Pfizer announced plans to advance a once-daily version of its weight loss pill, danuglipron, following encouraging early-stage trial results.
Best Stocks
3 Defensive Stocks to Protect Your Portfolio in 2024
Alcohol, tobacco and drugs are bulwarks against market shocks, and these three stocks are now trading under low ballparks.
Best Stocks
Three Stocks That Are Set Up for a Great Second Quarter of 2024
Culling the weak, but holding the strong.
Best Stocks
Three Safe Dividend Paying Stocks With High Yields to Hold in 2024
Three companies dominate their domains for high dividend yields.
Best Stocks
Pfizer Sinks Premarket After Posting Weak Guidance for 2024
Pfizer's shares plummeted 9% at Wednesday's market open after it issued a weaker-than-expected 2024 guidance.